This inventor holds 1 USPTO granted patent. Top assignee: Fuji Immunopharmaceuticals Corp.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Douglas F Marks, Jr: A Pioneer in Antimicrobial Innovation
Introduction
Douglas F Marks, Jr. is an esteemed inventor based in Sommerville, MA, who has made significant contributions to the field of dental health through his innovative research. With a focus on antimicrobial and anticollagenase properties, his groundbreaking work aims to combat oral diseases that affect millions.
Latest Patents
Marks holds a notable patent titled "Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide." This patent discloses chemical agents that exhibit unexpected antimicrobial activity against dangerous microbes such as Porphyromonas gingivalis, which is known for its role in the progression of conditions like gingivitis and periodontitis. The agents detailed in this patent also demonstrate anticollagenase activity that is particularly useful in mitigating tissue damage, showcasing their potential as valuable tools in managing periodontal diseases.
Career Highlights
Douglas F Marks, Jr. works with Fuji Immunopharmaceuticals Corp., a company dedicated to advancing health through innovative pharmaceutical solutions. His work is pivotal in the development of effective treatment modalities, particularly those that address tissue destruction caused by bacterial infections in oral health.
Collaborations
Throughout his career, Marks has collaborated with distinguished coworkers, including Mitsunori Ono and Y-s Edmond Cheng. These collaborations have facilitated further advancements in his research, allowing for a multidisciplinary approach to addressing significant health challenges within dental medicine.
Conclusion
In summary, Douglas F Marks, Jr. stands out as a visionary inventor whose work has far-reaching implications for dental health. His patented discoveries provide promising avenues for the treatment and management of periodontal diseases, contributing to improved oral care and health outcomes for patients. His ongoing research and collaborations continue to pave the way for innovative solutions in the field of immunopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile